home *** CD-ROM | disk | FTP | other *** search
- <text id=89TT2346>
- <title>
- Sep. 11, 1989: Business Notes:Pharmaceuticals
- </title>
- <history>
- TIME--The Weekly Newsmagazine--1989
- Sep. 11, 1989 The Lonely War:Drugs
- </history>
- <article>
- <source>Time Magazine</source>
- <hdr>
- BUSINESS, Page 59
- Business Notes
- PHARMACEUTICALS
- The Capsules That Flunked
- </hdr><body>
- <p> At first the growing generic drug-industry scandal was
- limited to a few unscrupulous newcomers. But last week the
- Government's probe of substandard generics struck an industry
- leader, Bolar Pharmaceutical of Copiague, N.Y. The Food and Drug
- Administration said that it intends to withdraw its approval of
- Bolar's generic version of Dyazide, the top-selling brand-name
- hypertension drug. Reason: the FDA says it can no longer be sure
- that the generic is biologically equivalent to its brand-name
- counterpart. After reviewing Bolar's records, the FDA found that
- the company had submitted two batches of its drug for approval
- in 1987. Only one passed the equivalency test, but it is unclear
- which version reached the market. Bolar claims that only the
- effective generic is in drugstores.
- </p>
-
- </body></article>
- </text>
-
-